JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
RCM
3776
DELISTED
R1 RCM Inc. Common Stock
RCM
| $401K | ﹤0.01% |
35,949
+1,725
| +5% | +$17.7K |
2017 Q4
10 quarters
|
|
3777
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.02B
| $400K | ﹤0.01% |
13,937
-834
| -6% | -$22.9K |
2019 Q1
5 quarters
|
|
3778
Helios Technologies
HLIO
$2.34B
| $397K | ﹤0.01% |
10,679
-3,490
| -25% | -$119K |
2016 Q3
15 quarters
|
|
3779
Travere Therapeutics
TVTX
$5.44B
| $397K | ﹤0.01% |
19,440
-81
| -0.4% | -$1.29K |
2016 Q4
14 quarters
|
|
3780
PUT
Vanguard Global ex-US Real Estate ETF
VNQI
$3.24B
| $396K | ﹤0.01% |
+10,000
| New | +$452K |
2020 Q2
0 quarters
|
|
3781
Forestar Group
FOR
$1.29B
| $395K | ﹤0.01% |
26,174
+20,783
| +386% | +$286K |
2013 Q2
28 quarters
|
|
3782
Victory Capital Holdings
VCTR
$7.09B
| $395K | ﹤0.01% |
22,952
+22,949
| +764,967% | +$360K |
2020 Q1
1 quarter
|
|
|
FRG
3783
DELISTED
Franchise Group, Inc.
FRG
| $395K | ﹤0.01% |
+18,075
| New | +$288K |
2020 Q2
0 quarters
|
|
3784
Invesco Short Term Treasury ETF
TBLL
$2.9B
| $394K | ﹤0.01% |
3,725
+950
| +34% | +$101K |
2019 Q4
2 quarters
|
|
3785
iShares New York Muni Bond ETF
NYF
$1.53B
| $393K | ﹤0.01% |
6,826
-215
| -3% | -$12.2K |
2015 Q4
18 quarters
|
|
3786
Invesco S&P 500 Pure Value ETF
RPV
$1.66B
| $393K | ﹤0.01% |
8,236
-1,149
| -12% | -$52.4K |
2013 Q2
28 quarters
|
|
3787
Immunovant
IMVT
$6.87B
| $392K | ﹤0.01% |
16,077
+13,169
| +453% | +$282K |
2020 Q1
1 quarter
|
|
3788
Invesco Solar ETF
TAN
$895M
| $392K | ﹤0.01% |
10,857
+4,780
| +79% | +$151K |
2017 Q2
12 quarters
|
|
3789
Heartland Express
HTLD
$902M
| $389K | ﹤0.01% |
18,677
-57,937
| -76% | -$1.16M |
2013 Q2
28 quarters
|
|
3790
Chord Energy
CHRD
$7.61B
| $388K | ﹤0.01% |
515,768
-871,985
| -63% | -$564K |
2016 Q4
14 quarters
|
|
3791
Castle Biosciences
CSTL
$1.12B
| $387K | ﹤0.01% |
10,265
-2,277
| -18% | -$77.8K |
2019 Q3
3 quarters
|
|
3792
Tower Semiconductor
TSEM
$28.2B
| $387K | ﹤0.01% |
20,247
-14,352
| -41% | -$275K |
2015 Q4
18 quarters
|
|
3793
Metallus
MTUS
$872M
| $387K | ﹤0.01% |
99,554
-207,889
| -68% | -$695K |
2017 Q4
10 quarters
|
|
3794
CALL
Ulta Beauty
ULTA
$23.2B
| $386K | ﹤0.01% |
1,900
-4,000
| -68% | -$860K |
2019 Q3
3 quarters
|
|
3795
Evolution Petroleum
EPM
$143M
| $384K | ﹤0.01% |
137,147
+41,507
| +43% | +$111K |
2017 Q3
11 quarters
|
|
3796
PUT
Ovintiv
OVV
$16.9B
| $384K | ﹤0.01% |
40,200
-59,800
| -60% | -$417K |
2020 Q1
1 quarter
|
|
3797
PUT
Alaunos Therapeutics
TCRT
$2.02M
| $383K | ﹤0.01% |
778
+728
| +1,456% | +$325K |
2019 Q1
5 quarters
|
|
|
AXNX
3798
DELISTED
Axonics, Inc. Common Stock
AXNX
| $381K | ﹤0.01% |
10,831
+4,506
| +71% | +$155K |
2018 Q4
6 quarters
|
|
|
BSX.PRA
3799
DELISTED
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
| $380K | ﹤0.01% |
+3,628
| New | +$389K |
2020 Q2
0 quarters
|
|
|
BPYU
3800
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $380K | ﹤0.01% |
38,169
+4,721
| +14% | +$47.5K |
2018 Q3
7 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.